Cancers, Vol. 11, Pages 1243: Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker

Conclusions: Plasmatic LDH and its variation during first-line treatment predict PFS and OS in MBC, providing independent prognostic information. It would be worthwhile to prospectively evaluate the association between LDH variation and therapeutic benefit in MBC, and explore how it may affect treatment strategies.

Source: Cancers - August 23, 2019 Category: Cancer & Oncology Authors: Giacomo Pelizzari Debora Basile Silvia Zago Camilla Lisanti Michele Bartoletti Lucia Bortot Maria Grazia Vitale Valentina Fanotto Serena Barban Marika Cinausero Marta Bonotto Lorenzo Gerratana Mauro Mansutti Francesco Curcio Gianpiero Fasola Alessandro Ma Tags: Article Source Type: research